Replicate Pilot study [Power / Sample Size]

posted by ElMaestro  – Denmark, 2014-04-11 12:27 (4449 d 20:15 ago) – Posting: # 12809
Views: 16,287

Hi Kumarnaidu,

❝ Cmax-62.57(38.27 - 102.29) CV-83.85

❝ AUCt-46.09(17.47 - 121.55) CV-263.48

❝ As per experts study failed drastically because of its design (2x2 cross over), and replicate design should be used here instead of 2x2 design.

❝ In my opinion there may be design issue but the test product is also not upto the mark. Please provide your suggestions. Is there a need of change in design of pilot study or test product modification?


Your estimate of CV's is conditional on the point estimates and thus GMR. If you believe in the CV's you believe in the GMRs. If you don't believe in either then I guess you should have a reason. Technical error during bioanalysis etc etc.
To me, as long as concerns over technical errors etc have not been raised, this just looks like a clear-cut failed development to me. I would not spend as much as $.02 on further studies on the present formulation.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
148 visitors (0 registered, 148 guests [including 15 identified bots]).
Forum time: 08:43 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5